Why this under-the-radar ASX 200 stock is in a trading halt

It looks like this top 200 company is ready to splash some cash again.

| More on:
A man on a phone call points his finger, indicating a halt in trading on the ASX share market.

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market is swinging into action this morning, with one exception among stocks inside the S&P/ASX 200 Index (ASX: XJO).

You'd be forgiven for not noticing. The company isn't in the same leagues as CSL Ltd (ASX: CSL) or Woolworths Group Ltd (ASX: WOW). However, at a market capitalisation of $3.2 billion, this arguably 'under-the-radar' company is hardly any small fry either.

If you haven't already guessed, I'm talking about the insurance broker and underwriting agency AUB Group Ltd (ASX: AUB). Shares in the company are locked at $29.46 this morning after AUB requested a trading halt ahead of the morning bell.

It turns out that AUB Group has some big news to share.

Acquisition to fill the gaps

AUB Group is ready to take its next bite of the merger and acquisition pie.

A year and a half after engulfing Tysers, AUB is deploying capital again to continue its growth through acquisition strategy. This time, a Melbourne-based specialist underwriting agency is at the centre of attention.

Pacific Indemnity, founded in 2015 by Jun Acance, has only been in business for eight and a half years. However, the professional indemnity-focused business conducted $177 million in gross written premiums in FY23.

The ASX 200 stock is acquiring 70% of the equity in Pacific Indemnity for $105 million. The offer values the acquisition target at an enterprise value of $192 million, giving it an enterprise value to FY23 earnings before interest and taxes multiple of 13 times.

A further $35 million is on the table, depending on the performance of Pacific Indemnity post-acquisition.

The rationale behind the deal is that Pacific Indemnity will cover gaps in AUB Group's existing capabilities. Furthermore, the company is said to be achieving high growth and margins, making it an attractive add-on for AUB.

Detailing the logic further, AUB Group CEO and managing director Mike Emmett states:

The acquisition of Pacific Indemnity will add scale, diversify our capabilities, and expand our expertise in financial lines. The acquisition also presents opportunities for mutual benefits across the business, through collaboration between Pacific Indemnity and the broader AUB Group.

Completion of the 70% stake is slated for 1 July 2024.

Tapping cash for this ASX 200 stock

AUB Group is also announcing an equity raising to fund the Pacific Indemnity deal.

The company will tap $200 million via an institutional placement, covering the total outlay for the 70% stake. In fact, $95 million of the placement is earmarked for 'cash to support M&A pipeline and cost of equity raising'.

Additionally, AUB Group will contemplate offering a share purchase plan for up to $25 million worth of new shares.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended Aub Group and CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Mergers & Acquisitions

Multiple ASX share investors take on one another in a tug of war in a high rise building.
Mergers & Acquisitions

Platinum shares slump despite Regal takeover update

Could a takeover deal be getting closer? Let's find out.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Sigma shares up 25% in 2 days as Chemist Warehouse merger looks set

The deal continues to create tailwinds for Sigma shares.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Small Cap Shares

Which small cap ASX stock is jumping 20% after receiving a takeover offer?

This tech stock could be heading to the NASDAQ after receiving a takeover offer.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Guess which ASX 200 healthcare stock is up 12% on big Chemist Warehouse news

Investors appear to believe this news could be a sign that the deal will go ahead.

Read more »

Happy woman holding white house model in hand and pointing to it with a pen.
Mergers & Acquisitions

REA share price charges higher on big Rightmove news

It wasn't fourth time lucky for the realestate.com.au operator.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Financial Shares

Platinum shares fall after rejecting Regal Partners takeover offer

The fund manager believes the offer undervalues the company.

Read more »

Happy woman standing in front of a house with a pen and clipboard.
Mergers & Acquisitions

REA Group shares drop on new $11.9 billion Rightmove offer

The property listings company is hoping it will be third time lucky.

Read more »

Shot of a young scientist looking stressed out while working on a computer in a lab.
Healthcare Shares

Guess which ASX 200 healthcare stock is tumbling despite announcing US$230m acquisition

The company is strengthening its position in the US market with a big purchase.

Read more »